For the treatment of prostatic hypertrophy

ID: 23

Pack Weight: 50 g.

Price: 21 $        

Pharmaceutical Form: Herbal MEDICAL Mixtures

Ingredients:

- Urtica diocia.
- Cinnamomum aromaticum.
- Pumpkin seed.
- Populus Alba/ Buds.

Indications:

This formula is indicated for:
Benign prostatic hyperplasia (BPH) also known as Nodular hyperplasia, and Benign prostatic hypertrophy or Benign enlargement of the prostate (BEP) refers to the increase in size of the prostate in middle-aged and elderly men.
Also this product considers safe diuretic, enhance the blood irrigation system, and support the general state of the patient.

Science behind this formula:
- Pumpkin seed:
Approved experimentally and in many clinical trials (randomized double- blind placebo) for benign prostatic hyperplasia BPH. PDR
The efficacy of lipophilic pumpkin seed extracts or pumpkin seed oil for micturation complaints accompanying benign prostatic hyperplasia or irritable bladder has been confirmed by several clinical and experimental studies. As wll as amaroids (cucurbitacin), the drug contains delta-7- sterols which are similar in conformation to the dihydrosteseterone. Pumpkin is also antiphlogistic and antioxidative. PDR
Pumpkin seed is approved by commission e/ Germany for:
Prostate complaints.
Irritable bladder.

- Urtica diocia:
ABSTRACT:
In an open-label extension of a randomized, double-blind clinical trial, the long-term efficacy and tolerability of a fixed combination of 160 mg Sabal fruit extract WS 1473 and 120 mg Urtica root extract WS 1031 per capsule (PRO 160/120) were investigated in elderly men with moderate or severe lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). Two hundred and fifty-seven patients were randomly treated with 2 x 1 capsule/day PRO 160/120 or placebo for 24 weeks, followed by a 24-week control period and a 48-week follow-up period in which all patients received PRO 160/120. Efficacy measures included the assessment of LUTS [International Prostate Symptom Score ((I-PSS) self-rating questionnaire] and uroflow and sonographic parameters. Two hundred and nineteen subjects participated in the follow-up. Between baseline and end of observation (week 96) the I-PSS total score was reduced by 53% (P

Dosage and Administration:

Dosage and Administration:
middle spoon , or tea bag from the mixture to a glass of boiled water /capacity of 200 ml. ( boiled previously) then cover it for ten minutes, filter it and have it warm half an hour before the meal.
Therapeutically: 2-3 times daily.
Prophylactically: once daily.

What is BPH:
Benign prostatic hyperplasia (BPH) also known as Nodular hyperplasia, Benign prostatic hypertrophy or Benign enlargement of the prostate (BEP) refers to the increase in size of the prostate in middle-aged and elderly men. To be accurate, the process is one of hyperplasia rather than hypertrophy, but the nomenclature is often interchangeable, even amongst urologists. It is characterized by hyperplasia of prostatic stromal and epithelial cells, resulting in the formation of large, fairly discrete nodules in the periurethral region of the prostate. When sufficiently large, the nodules compress the urethral canal to cause partial, or sometimes virtually complete, obstruction of the urethra which interferes the normal flow of urine. It leads to symptoms of urinary hesitancy, frequent urination, increased risk of urinary tract infections and urinary retention. Although prostate specific antigen levels may be elevated in these patients, because of increased organ volume and inflammation due to urinary tract infections, BPH is not considered to be a premalignant lesion.